Leonteq Securities’s Sarepta Therapeutics SRPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$247K Buy
13,539
+7,694
+132% +$144K 0.01% 461
2026
Q2
$105K Buy
5,845
+2,282
+64% +$43.2K ﹤0.01% 679
2026
Q1
$77.5K Buy
3,563
+37
+1% +$716 ﹤0.01% 783
2025
Q4
$75.9K Sell
3,526
-7,859
-69% -$166K ﹤0.01% 869
2025
Q3
$219K Buy
11,385
+4,953
+77% +$88.3K 0.01% 592
2025
Q2
$110K Buy
6,432
+2,961
+85% +$126K ﹤0.01% 702
2025
Q1
$220K Buy
3,471
+1,129
+48% +$119K 0.01% 521
2024
Q4
$285K Buy
2,342
+2,107
+897% +$258K 0.02% 468
2024
Q3
$29.3K Buy
235
+231
+5,775% +$31.9K ﹤0.01% 859
2024
Q2
$632 Sell
4
-734
-99% -$94.3K ﹤0.01% 1145
2024
Q1
$95.5K Buy
+738
New +$90.4K 0.01% 643
2023
Q3
– Sell
-90
Closed -$10.3K – 1288
2023
Q2
$10.3K Hold
90
– – ﹤0.01% 1036
2023
Q1
$12.4K Buy
90
+89
+8,900% +$11.5K ﹤0.01% 989
2022
Q4
$130 Sell
1
-11
-92% -$1.28K ﹤0.01% 1260
2022
Q3
$1.33K Sell
12
-10
-45% -$1.01K ﹤0.01% 1203
2022
Q2
$1.65K Buy
22
+21
+2,100% +$1.54K ﹤0.01% 1213
2022
Q1
$78 Hold
1
– – ﹤0.01% 1222
2021
Q4
$90 Buy
+1
New +$85 ﹤0.01% 1242
2021
Q3
– Sell
-1,200
Closed -$93.3K – 1214
2021
Q2
$93.3K Sell
1,200
-400
-25% -$30.3K 0.01% 725
2021
Q1
$119K Buy
1,600
+1,050
+191% +$96.9K 0.01% 646
2020
Q4
$93.8K Buy
+550
New +$81.5K 0.01% 692

Other funds holding SRPT

Leonteq Securities's SRPT Position: Q3 2026 in Review

Leonteq Securities increased its Sarepta Therapeutics (SRPT) stake by 132% in Q3 2026, buying an estimated $144K and bringing the position to 13,539 shares worth $247K. The position accounts for 0.01% of the portfolio, ranked #461.

Leonteq Securities first reported a position in SRPT in Q4 2020 and has held it in 21 quarters since. The position peaked at $285K in Q4 2024. 299 funds tracked by Wall St. Rank hold SRPT as of Q3 2026.

  • Leonteq Securities held 13,539 shares of Sarepta Therapeutics worth $247K as of Q3 2026.
  • Leonteq Securities bought 7,694 Sarepta Therapeutics shares in Q3 2026, an estimated $144K.
  • Sarepta Therapeutics made up 0.01% of Leonteq Securities's portfolio in Q3 2026, its #461 holding.
  • Leonteq Securities first reported a position in Sarepta Therapeutics in Q4 2020 and has held it in 21 quarters since.
  • Leonteq Securities's Sarepta Therapeutics position peaked at $285K in Q4 2024.
  • 299 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q3 2026.

Based on Leonteq Securities's 13F filing for Q3 2026, filed 29 Oct 2026.